Nadira Duraković
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation 12
- Molecular Medicine top 10%
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Chronic Lymphocytic Leukemia Research 3
-
- T-cell and B-cell Immunology 7
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 3
-
- Acute Lymphoblastic Leukemia research 4
-
- Polyomavirus and related diseases 3
- Co-authors
- Vedran RadojčićRadovan VrḫovacEphraim J. FuchsDamir NemetDubravka SertićMario ŠkaricaBoris LabarZinaida Perić
- Cited by
- HematologyMolecular MedicineGenetics
- Journals
- SHILAP Revista de lepidopterología (1 paper)Blood (5 papers)The Journal of Immunology (1 paper)
- Partner nations
- CroatiaUnited StatesUnited Kingdom
In The Last Decade
Nadira Duraković
32 papers receiving 257 citations
Peers
Comparison fields: 5 of 50
- Hematology 132
- Molecular Medicine 35
- Genetics 66
- Applied Microbiology and Biotechnology 8
- Immunology 79
Countries citing papers authored by Nadira Duraković
This map shows the geographic impact of Nadira Duraković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadira Duraković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadira Duraković more than expected).
Fields of papers citing papers by Nadira Duraković
This network shows the impact of papers produced by Nadira Duraković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadira Duraković. The network helps show where Nadira Duraković may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nadira Duraković, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 1 | |
| 6 | 2020 | 6 | |
| 7 | 2019 | 9 | |
| 8 | 2019 | 2 | |
| 9 | 2018 | 4 | |
| 10 | 2018 | 25 | |
| 11 | 2018 | 18 | |
| 12 | 2018 | 34 | |
| 13 | 2017 | 8 | |
| 14 | 2016 | 2 | |
| 15 | 2016 | 10 | |
| 16 | Late complications (LC) and quality of life (QOL) after allogeneic stem cell transplantation (allo-SCT) | 2015 | 1 |
| 17 | 2010 | 1 | |
| 18 | Dvadeset godina liječenja teške aplastične anemije u Zavodu za hematologiju Klinike za unutrašnje bolesti Kliničkog bolničkog centra Zagreb | 2009 | 1 |
| 19 | 2007 | 24 | |
| 20 | 2006 | 30 |
About Nadira Duraković
Nadira Duraković is a scholar working on Hematology, Genetics and Immunology, having authored 34 papers that have together received 261 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (12 papers), T-cell and B-cell Immunology (7 papers), Immune Cell Function and Interaction (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Polyomavirus and related diseases (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Hematology (132 citations), Molecular Medicine (35 citations) and Genetics (66 citations). Nadira Duraković has collaborated with scholars based in Croatia, United States and United Kingdom. Frequent co-authors include Vedran Radojčić, Radovan Vrḫovac, Ephraim J. Fuchs, Damir Nemet, Dubravka Sertić, Mario Škarica, Boris Labar, Zinaida Perić, Ana Boban and Dražen Pulanić. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.